BIOA 8-K 2026-01-12

BioAge Labs, Inc. (BIOA) 8-K dated 2026-01-12 — accession 0001193125-26-009911. This URL is the filing, not the BIOA hub.

BioAge Labs, Inc. (BIOA) is a drug manufacturers - specialty & generic company listed on US.

BioAge Labs, Inc. filed a 8-K on 2026-01-12. Accession 0001193125-26-009911.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported BIOA revenue for 2025-12-31 was $9.0M. Net income was -$80.6M. BIOA currently screens at market cap $697.9M.

Not investment advice. The BIOA SEC hub lists recent forms. The stock page is the research view.